Back to ABT
KBC Group NV ABT Position History
Abbott Laboratories • Healthcare
Quarters held
21
Latest value
$424K
Q3 2026
Peak value
$268.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $17M |
| Q3 2025 | $118.7M |
| Q3 2025 | $1.1M |
| Q4 2025 | $16M |
| Q4 2025 | $4M |
| Q4 2025 | $23.4M |
| Q4 2025 | $113.6M |
| Q4 2025 | $268.7M |
| Q4 2025 | $172K |
| Q4 2025 | $1.2M |
| Q4 2025 | $3.3M |
| Q4 2025 | $0 |
| Q1 2026 | $3.1M |
| Q1 2026 | $97.1M |
| Q1 2026 | $996K |
| Q2 2026 | $2.7M |
| Q2 2026 | $84.4M |
| Q2 2026 | $1.1M |
| Q3 2026 | $3M |
| Q3 2026 | $48.7M |
| Q3 2026 | $424K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $424K | 4.3K | — | — |
| Q3 2026 | $48.7M | 492.6K | — | — |
| Q3 2026 | $3M | 30.2K | — | — |
| Q2 2026 | $1.1M | 11.6K | — | — |
| Q2 2026 | $84.4M | 929.8K | — | — |
| Q2 2026 | $2.7M | 30.2K | — | — |
| Q1 2026 | $996K | 9.7K | — | — |
| Q1 2026 | $97.1M | 945.9K | — | — |
| Q1 2026 | $3.1M | 30.5K | — | — |
| Q4 2025 | $0 | 62 | — | — |
| Q4 2025 | $3.3M | 14.6K | — | — |
| Q4 2025 | $1.2M | 9.7K | — | — |
| Q4 2025 | $172K | 1.4K | — | — |
| Q4 2025 | $268.7M | 1.18M | — | — |
| Q4 2025 | $113.6M | 906.5K | — | — |
| Q4 2025 | $23.4M | 67.0K | — | — |
| Q4 2025 | $4M | 17.5K | — | — |
| Q4 2025 | $16M | 127.5K | — | — |
| Q3 2025 | $1.1M | 8.0K | — | — |
| Q3 2025 | $118.7M | 886.3K | — | — |
| Q3 2025 | $17M | 126.7K | — | — |
Other funds holding ABT
$22.4B
$21.5B
$19.8B
$10.7B
$10.5B
$10.3B